Article

Whiplash recovery expectations predict recovery

A patient’s expectations for recovery from a whiplash-associated disorder (WAD), measured in the first 6 weeks after a traffic-related WAD, predict actual recovery. Pain recovery and resolution of pain-related limitations show a similar pattern.

A patient’s expectations for recovery from a whiplash-associated disorder (WAD), measured in the first 6 weeks after a traffic-related WAD, predict actual recovery. Pain recovery and resolution of pain-related limitations show a similar pattern.

Carroll and coworkers evaluated 6015 adults who had sustained a whiplash injury during the previous year to determine whether patients’ estimation of their recovery influenced actual outcome. Recovery was evaluated according to global self-assessment, self-rated neck pain intensity, and self-reported limitations in daily activities.

Persons who expected to improve quickly healed more than 3 times sooner than those who did not expect to return to normal. Recovery time in persons who thought they would heal slowly was intermediate-about 2.5 times faster than those who thought they would not heal. Persons who claimed to have no idea of how soon they would recover healed more slowly but still improved more rapidly than self-proclaimed nonhealers. This pattern was consistent across all 3 recovery indices.

The authors suggeisted that several psychological factors (eg, coping, depression, and anxiety) are important in recovery from a WAD and that assessing expectations for recovery is worthwhile as a means of identifying injured patients at risk for poor recovery.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
© 2024 MJH Life Sciences

All rights reserved.